RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
The Latest on: Viral diseases
- Residents of flood-hit areas urged to beware of infectious diseases on December 12, 2017 at 7:47 am
BANGKOK, 12 December 2017 (NNT) – The Ministry of Public Health has instructed related officials in flood-affected areas to take special care of residents due to a possible outbreak of flood-related illnesses. Deputy Permanent Secretary for Public Health ... […]
- Detailed examination of the Middle East and Africa's infectious disease therapeutics market is projected to reach $ 10.54 billion by the end of 2021 on December 12, 2017 at 2:50 am
Infectious Diseases Diagnostics Market By Product, Technology, End User And By Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To 2021). Middle East and Africa Infectious Disease Therapeutics Market was worth $ 7.22 ... […]
- Yellowstone rams catch disease causing unsightly mouth sores on December 11, 2017 at 5:48 pm
BOZEMAN, Mont. (AP) — Yellowstone National Park officials say multiple bighorn rams have caught a viral disease that causes unsightly mouth sores. The Bozeman Daily Chronicle reports the park's videographer snapped images in November of rams with the sores. […]
- Virus blamed for sore mouth disease in Yellowstone bighorns on December 11, 2017 at 12:28 pm
MAMMOTH HOT SPRINGS, Wyo. (KIFI/KIDK) - Yellowstone National Park biologists believe a contagious ecthyma called "sore mouth disease" is responsible for an illness found in bighorn rams in the park. The disease is a virus caused by the parapoxvirus. […]
- Infectious disease expert says to 'not worry' about ticks on Christmas trees on December 10, 2017 at 7:22 am
There has been a buzz as of late regarding the precautions people should take when going Christmas tree shopping and what else you could be bringing into your home. An article from last week noted the dangers of the Lone Star tick, its migration north and ... […]
- Uganda ends Marburg virus disease outbreak on December 8, 2017 at 10:11 pm
Geneva, 8 December 2017 – Uganda has successfully controlled an outbreak of Marburg virus disease (MVD) and prevented its spread only weeks after it was first detected, the World Health Organization said on Friday (December 8). “Uganda has led an ... […]
- Champions for Humanity Distributes Ionic Silver to Help Save Millions from Infectious Disease on December 8, 2017 at 3:09 pm
FORT LAUDERDALE, Fla., Dec. 8, 2017 (SEND2PRESS NEWSWIRE) –- Jay Newman, founder and executive director of Champions for Humanity, founded this tax exempt 501(c)(3) charitable organization to bring a leading-edge embodiment of ionic silver – Opti ... […]
- North America Infectious Disease Testing Market: Canada, Mexico, US-Sales and Volume Forecasts for 100 Microbiology Tests on December 7, 2017 at 2:54 pm
Portland, OR -- (SBWIRE) -- 12/07/2017 -- This new report from Research Beam provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to ... […]
- UofL researchers develop novel flu virus and disease detection method on December 7, 2017 at 7:00 am
Using lasers, electricity, very thin film and their expertise in physics and biology, University of Louisville researchers have developed a method for early detection of diseases, such as the flu, dengue fever and even cancer. They hope that their approach ... […]
- BU infectious disease lab gets clearance to work with Ebola, Marburg viruses on December 7, 2017 at 2:30 am
Boston University researchers will now be allowed to work with pathogens as viral as Ebola, following the upgrade of one of its labs being upgraded to a Biosafety Level 4 facility by the Boston Public Health Commission. The upgrade to Level 4 for Boston ... […]
via Google News and Bing News